Chan Zuckerberg Biohub

Biotech · Private

Cross-disciplinary biomedical research platform for infectious disease study and cell atlas mapping

czbiohub.org →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
40
3 granted · 37 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1622Furtim Therapeutics LLC——
1623NOVALEX THERAPEUTICS, INC.——
1624RADIKAL THERAPEUTICS, INC.——
1625Chan Zuckerberg Biohub——
1626ERADIVIR, INC.——
1627Sarkar-Klein-Labs——
1628Wildflower Biopharma Inc——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 3 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.